Common presentations of nontuberculous mycobacterial infections

Pediatric Infectious Disease Journal

Volumn 33, Issue 1, 2014, Pages 89-91

  Hatzenbuehler, Lindsay A ^a   Starke, Jeffrey R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ETHAMBUTOL; IMIPENEM; ISONIAZID PLUS RIFAMPICIN; LINEZOLID; MACROLIDE; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE;

ABSCESS DRAINAGE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BARTONELLA HENSELAE; CYSTIC FIBROSIS; CYSTIC LYMPHANGIOMA; EPSTEIN BARR VIRUS; EXCISION; HUMAN; LYMPHADENITIS; MONOTHERAPY; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CELATUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM CONSPICUUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM MARINUM; MYCOBACTERIUM ULCERANS; NONTUBERCULOUS MYCOBACTERIAL INFECTION; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; TOXOPLASMA GONDII;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; HUMANS; LYMPHADENITIS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 84891510086     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000170     Document Type: Article

References (11)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et al.; AT S Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official AT S/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416
2. Lindeboom JA, Kuijper EJ, Bruijnesteijn Van Coppenraet ES, et al. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: A multicenter, randomized, controlled trial. Clin Infect Dis. 2007;44:1057-1064
3. Lindeboom JA. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. J Oral Maxillofac Surg. 2012;70:345-348
4. Luong A, McClay JE, Jafri HS, et al. Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis. Laryngoscope. 2005;115:1746-1751
5. Lindeboom JA, Lindeboom R, Bruijnesteijn Van Coppenraet ES, et al. Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Infect Dis J. 2009;28:1028-1030
6. Franklin DJ, Starke JR, Brady MT, et al. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: A new clinical entity? Am J Otol. 1994;15:313-320
7. Olivier KN, Weber DJ, Wallace RJ Jr, et al Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167: 828-834
8. Olivier KN, Weber DJ, Lee JH, et al.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003;167:835-840
9. Esther CR Jr, Esserman DA, Gilligan P, et al. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros. 2010;9:117-123
10. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved Standard. Wayne, PA: NCCLS; 2003. Document No. M24-A.
11. N ienhuis WA, Stienstra Y, Thompson WA, et al. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: A randomised controlled trial. Lancet. 2010;375:664-672